Interleukin‐10 Suppresses the Development of Collagen Type II‐Induced Arthritis and Ameliorates Sustained Arthritis in Rats
The DOI matches its Crossref record.
Abstract
The collagen‐induced arthritis model in DA rats induced with homologous rat type II collagen was chosen to determine the therapeutic capacity and effects on autoimmunity by IL‐10. Systemic IL‐10 treatment (100 or 10 μg/day) with mini‐osmotic pumps during the periods of arthritis onset (days 12–20 after immunization) decreased the frequency of arthritis and delayed the onset and reduced the severity of arthritis in the few rats that eventually developed arthritis. Concomitantly, levels of autoantibodies to CII were reduced. To test the activity on established arthritis, IL‐10 was administered subcutaneously in the paws. This treatment reduced the swelling but did not block the arthritis process. The effective treatment required 100 μg of IL‐10 every 12th hour while 50 μg of IL‐10 had little effect, although a tendency of reduced paw swelling was observed. Surprisingly, therapeutic IL‐10 treatment led to higher serum levels of autoantibodies to CII. The highest doses of IL‐10 (100 μg) did not show any apparent toxic effects when given locally or systematically. Taken together, this study suggests that IL‐10 is a candidate for treatment of rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Self-citationInterleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
Crawley, E., Kay, R., Sillibourne, J., Patel, P., Hutchinson, I., & Woo, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1101::aid-anr6>3.0.co;2-y · Cited by 530
Saxena, A., Khosraviani, S., Noel, S., Mohan, D., Donner, T., & Hamad, A. R. A. (2015) · Cytokine · doi:10.1016/j.cyto.2014.10.031 · Cited by 306
Hata, H., Sakaguchi, N., Yoshitomi, H., Iwakura, Y., Sekikawa, K., Azuma, Y., Kanai, C., Moriizumi, E., Nomura, T., Nakamura, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421795 · Cited by 304
Metadata
- Authors
- PERSSON, S., MIKULOWSKA, A., NARULA, S., O'GARRA, A., & HOLMDAHL, R.
- Venue
- Scandinavian Journal of Immunology
- Publisher
- Wiley
- Published
- 1996-11
- Volume
- 44
- Issue
- 6
- Pages
- 607-614
- ISSN
- 0300-9475 (ISSN-L)
- 1365-3083
- OpenAlex
- W2046348302
- Cited by
- 103
- References
- 0
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interleukin‐10 Suppresses the Development of Collagen Type II‐Induced Arthritis and Ameliorates Sustained Arthritis in Rats. https://app.cochat.ai/papers/10.1046/j.1365-3083.1996.d01-355.x
- The paper
- PERSSON, S., MIKULOWSKA, A., NARULA, S., O'GARRA, A., & HOLMDAHL, R. (1996). Interleukin‐10 Suppresses the Development of Collagen Type II‐Induced Arthritis and Ameliorates Sustained Arthritis in Rats. Scandinavian Journal of Immunology. https://doi.org/10.1046/j.1365-3083.1996.d01-355.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.